The board of directors of Morepen Laboratories Limited has approved the investment proposed by Corinth Group, a global private investment group, headquartered in Switzerland, to the extent of USD 32.50 million in the parent company, Morepen Laboratories Limited out of a total USD 100 million investment in the promoter group.